The nation of Zimbabwe has declined a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of the United States' demand for sensitive data.
This rejection became public following a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the deal was "lopsided".
An official spokesman has since explained that the US was demanding access to health data for research and commercial gain while was not willing to share the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable task of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for continued negotiations to find a agreement agreeable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Implications
Zimbabwe's decision comes after a comparable case in Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the safety of Kenyans' health data.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had administered aid for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government deals to boost openness and responsibility.
According to reports, 16 African countries have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration could have provided immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to share its biological resources and data over an extended period, with no equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," his statement read.
"In essence, our nation would provide the raw materials for scientific discovery without any certainty that the final treatments would be available to our people should a new pandemic arise."
National Interest and Global Health
He also said that the US's withdrawal from the global health body and its push of bilateral deals were upending systems previously set up through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with potential pandemics.
"This system is intended to guarantee that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.
"We welcome ongoing discussions with our US partners on how future co-operation could be arranged in a manner that respects the sovereignty and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but recommended that negotiations should continue given that much of the country's HIV programmes were funded by international support.
"In cases where specific concerns arise, including those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," the group said.
This impasse emphasises the ongoing tensions between accepting vital foreign assistance and protecting local interests in an increasingly data-driven world.